Coco Healthcare(301009)
Search documents
可靠股份(301009) - 2025年8月24日投资者关系活动记录表
2025-08-25 09:52
Group 1: Financial Performance - The company's Q2 profit decreased compared to Q1 primarily due to promotional activities during the 618 sales event, impacting overall profitability [1] - The average price of adult care products remained stable compared to the previous year, with no significant data reflecting the "high price, high value" strategy in Q1 [2] - The gross profit margin in Q2 slightly declined due to the influence of the 618 promotional period [4] Group 2: Sales and Marketing Strategy - The company plans to maintain a steady investment in brand promotion while optimizing sales efficiency without necessarily increasing expenditure [2] - The sales expense ratio for the second half of the year is expected to improve compared to the same period last year [2] - The company aims for double-digit revenue growth in the second half, despite increased market competition [5] Group 3: Product Development and Innovation - The company has identified consumer pain points and is focusing on upgrading and expanding its product line, particularly in adult incontinence products [3] - High-margin products, such as cranberry products, currently have a small share in the adult incontinence product structure, as they are still in the early stages of market introduction [3] - The company plans to slow down the introduction of differentiated products while concentrating on developing flagship products like "Absorption Treasure" [3] Group 4: Market Expansion and Partnerships - The company has seen growth in institutional and specialty channel expansions, with online and offline growth rates being comparable [4] - The partnership with He Sheng Yuan for baby care products has ended, but the company plans to launch its own brand, Dudi, in Q2 2024, with a 116% year-on-year revenue increase for the brand by mid-2025 [4][5] - The company's self-branded products in the baby care segment currently account for less than 10% of the approximately 200 million revenue generated in that category [5]
可靠股份实控人金利伟前妻反对新董秘,称其“更适合董事长秘书”
Sou Hu Cai Jing· 2025-08-25 08:44
Core Viewpoint - The company is facing internal governance issues, particularly regarding the appointment of Wang Xiangting as the deputy general manager and board secretary, which has been opposed by board member Bao Jialian due to concerns over Wang's qualifications and experience [1][3]. Group 1: Governance Issues - Bao Jialian has cast three consecutive votes against the appointment of Wang Xiangting, citing a lack of professional knowledge, experience, and good professional ethics [1]. - Bao criticized Wang for being out of touch with the rules of listed companies since leaving his previous position in 2021, indicating that he relies heavily on colleagues in the securities department to perform his duties [3]. - The company has experienced significant turnover in its management, with nearly ten executives changing in two years, primarily due to conflicts between short-term needs of the chairman and long-term compliance requirements [3]. Group 2: Shareholding Structure - As of June 2025, Bao Jialian holds 29.13% of the company's shares, making her the second-largest shareholder, while the largest shareholder, Jin Liwei, holds 30.13% [5]. Group 3: Company Performance - Reliable Co., Ltd. reported a revenue of 549 million yuan for the first half of 2025, representing a year-on-year increase of 5.4% [6]. - The net profit attributable to the parent company was 28.28 million yuan, up 21.8% year-on-year, while the net profit excluding non-recurring items was 24.85 million yuan, reflecting a 15.4% increase [6].
可靠股份聘王向亭任副总兼董秘!20年资本经验加持,上半年营收5.49亿增5.39%,股价年内涨48.56%
Xin Lang Zheng Quan· 2025-08-25 05:38
Core Viewpoint - The appointment of Wang Xiangting as the new Deputy General Manager and Board Secretary of Reliable Co., Ltd. is seen as a significant step towards enhancing the company's governance structure and capital operation capabilities, which is expected to accelerate its development in the adult care products sector [2][4]. Group 1: Management Changes - Wang Xiangting has nearly 20 years of experience in large manufacturing and technology companies, particularly in capital operations and corporate governance [2]. - His previous roles include positions at Guangfa Securities, Hengdian Group, Zhejiang Wanma Cable Co., and Zhejiang Jiemai Electronics, where he was involved in multiple capital operations and the establishment of information disclosure systems [2]. Group 2: Company Performance - Reliable Co., Ltd. reported a total operating income of 549 million yuan for the first half of 2025, representing a year-on-year increase of 5.39%, and a net profit attributable to shareholders of 28 million yuan, up 21.81% year-on-year [4]. - The company has shown robust profitability despite fluctuations in raw material prices and changes in consumer demand, attributed to ongoing product structure optimization and an increased focus on mid-to-high-end products [4]. Group 3: Market Position and Strategy - Reliable Co., Ltd. is a leading manufacturer in the adult diaper industry and has been involved in drafting national standards for adult diapers and pads, maintaining a strong competitive position and industry influence [4]. - The company is expanding its "Reliable Welfare" brand to focus on the silver economy, innovating products and applications for elderly care in various settings, which opens up greater growth opportunities [5]. Group 4: Shareholder Returns - In 2024, Reliable Co., Ltd. implemented a cash dividend of 0.70 yuan per share (before tax), totaling 18.6497 million yuan, reflecting the company's commitment to providing long-term returns to shareholders [4]. Group 5: Stock Performance - As of August 25, the stock price of Reliable Co., Ltd. was 15.80 yuan per share, with a year-to-date increase of 48.56%, indicating market confidence in the company's long-term strategic direction and industry prospects [5].
可靠股份:上半年净利润同比增长21.81% 经营性现金流净额显著改善
Zhong Zheng Wang· 2025-08-25 04:55
Group 1 - The company reported a revenue of 549 million yuan for the first half of 2025, representing a year-on-year growth of 5.39% [1] - The net profit attributable to shareholders reached 28.28 million yuan, with a year-on-year increase of 21.81% [1] - The net cash flow from operating activities significantly increased by 157.71% to 41.38 million yuan, attributed to sales growth and improved collections [1] Group 2 - The company aims to become a world-class leader in the health care industry, having started its operations in 2001 with a focus on ODM business for baby and adult diapers [1] - The company has established an integrated operating model covering research, production, supply, and sales, allowing for effective control over the entire industry chain [2] - The company has built the first provincial enterprise research institute in the industry, the Zhejiang Reliable Care Innovation Research Institute, and has participated in over 20 national and group standards while holding more than 200 authorized patents [2] Group 3 - In procurement, the company adopts a sales-driven production approach and has established a comprehensive procurement management system [2] - The company has invested in upstream enterprises of core raw materials to create a stable supply chain and achieve cost leadership [2] - The company has made significant investments in smart manufacturing to enhance digitalization, informatization, and intelligence in its factories [2] Group 4 - The company has achieved full-channel coverage for its self-owned brand sales, with online presence on platforms like Tmall, JD, and Pinduoduo, as well as exploring new channels such as live streaming and community group buying [2] - Offline, the company is expanding into new channels such as long-term care insurance, elderly care institutions, and stores near hospitals [2]
可靠股份:2025年上半年净利润2827.86万元,同比增长21.81%
Jing Ji Guan Cha Wang· 2025-08-25 04:54
经济观察网 2025年8月24日,可靠股份(301009)发布2025年半年度报告,2025年上半年实现营业收入 5.49亿元,同比增长5.39%;实现净利润2827.86万元,同比增长21.81%;基本每股收益0.1061元;加权 平均净资产收益率ROE为2.10%。 ...
实控人前妻炮轰新董秘,可靠股份内斗激化
Zhong Jin Zai Xian· 2025-08-25 02:15
Core Viewpoint - The ongoing conflict between the actual controller of Reliable Shares, Jin Liwei, and his ex-wife, Bao Jia, continues to escalate, particularly regarding the appointment of a new secretary and issues related to corporate governance and compliance [1][4]. Group 1: Board Meeting and Voting - Bao Jia opposed three out of four proposals during the board meeting, specifically criticizing the appointment of Wang Xiangting as the new secretary due to concerns over his qualifications and potential risks [1][3]. - Despite Bao Jia's objections and the abstention votes from independent director Jing Naiquan, all related proposals were ultimately approved by the board [1][3]. Group 2: Background of New Secretary - Wang Xiangting was appointed as the new secretary after a series of frequent changes in this position, with the company having a history of rapid turnover in its secretarial roles since its A-share listing in June 2021 [2]. - Prior to joining Reliable Shares, Wang had experience as a secretary in other listed companies, but his recent departure from the industry raised concerns about his familiarity with current regulations [2][3]. Group 3: Concerns Over Qualifications and Performance - Bao Jia expressed doubts about Wang Xiangting's ability to perform effectively, citing his lack of recent experience in the securities field and errors in board documents [3][4]. - Independent director Jing Naiquan also raised concerns about Wang's attention to detail and professionalism, leading to his abstention vote [3]. Group 4: Related Party Transactions and Compliance Issues - Bao Jia highlighted potential violations regarding related party transactions that exceeded regulatory thresholds, which are currently under investigation by the Zhejiang Securities Regulatory Bureau [4][5]. - The company acknowledged the transactions but claimed they were not intentional violations, attributing the issues to misunderstandings regarding the timing of disclosures [5][6]. Group 5: Financial Performance and Governance Challenges - The performance of Reliable Shares has been a point of contention, with Bao Jia criticizing Jin Liwei for making poor investment decisions and the company's overall financial decline since its IPO [6]. - Reliable Shares experienced significant profit reductions post-listing, with a notable loss in 2022, although there has been some recovery in 2023 [6].
实控人前妻炮轰新董秘,可靠股份内斗激化
财联社· 2025-08-25 01:20
Core Viewpoint - The ongoing conflict between the controlling shareholder Jin Liwei and his ex-wife Bao Jia at Reliable Shares (301009.SZ) continues to escalate, particularly regarding the appointment of the new secretary and concerns over corporate governance and compliance issues [1][4]. Group 1: Board Meeting and Voting - On August 21, during the 11th meeting of the 5th board of directors, Bao Jia voted against three out of four proposals, including the appointment of Wang Xiangting as the new vice president and board secretary, citing concerns over his qualifications and potential risks [1][3]. - Despite Bao Jia's objections and the independent director Jing Naiquan abstaining from voting on some proposals, all relevant motions were ultimately passed [1][3]. Group 2: New Secretary's Background - Wang Xiangting was appointed as the new board secretary after a series of frequent changes in this position since the company's IPO in June 2021, with previous secretaries serving very short tenures [2]. - Prior to joining Reliable Shares, Wang had experience as a board secretary at other listed companies but had not worked in a securities role for several years [2][3]. Group 3: Concerns Over Wang Xiangting's Competence - Bao Jia criticized Wang's lack of familiarity with current securities regulations and his reliance on the securities department for completing tasks, leading to errors in board documents [3][4]. - There were complaints about Wang's attitude towards assisting employees with stock-related matters, which Bao Jia viewed as obstructive to the board's functioning [3][4]. Group 4: Related Party Transactions and Compliance Issues - Bao Jia raised alarms about potential violations regarding related party transactions, noting that transactions in Q1 2025 exceeded the regulatory threshold of 300,000 yuan and 0.5% of the company's audited net assets [5][6]. - The Zhejiang Securities Regulatory Bureau is currently investigating these transactions, which occurred shortly after Wang's appointment, raising questions about his accountability [5][6]. Group 5: Company Performance and Governance Issues - The performance of Reliable Shares has been a point of contention, with Bao Jia accusing Jin Liwei of making poor investment decisions, including investing in a loss-making company [7]. - Since its IPO, the company's profitability has significantly declined, with a notable loss in 2022, although there has been some recovery in 2023 [7].
杭州可靠护理用品股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-24 18:13
证券代码:301009 证券简称:可靠股份 公告编号:2025-032 一、重要提示 本半年度报告摘要来自半年度报告全文,为全面了解本公司的经营成果、财务状况及未来发展规划,投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 董事、监事、高级管理人员异议声明 ■ 董事、监事、高级管理人员异议声明的风险提示 董事鲍佳对公司2025年半年度报告及其摘要投反对票,请投资者特别关注。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利,不送红股,不以公积金转增股本。 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位:股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 1、公司简介 ■ 2、主要会计数据和财务指标 □适用 √不适用 公司是否 ...
可靠股份: 董事会决议公告
Zheng Quan Zhi Xing· 2025-08-24 16:16
Group 1 - The board meeting of Hangzhou Reliable Nursing Products Co., Ltd. was held on August 21, 2025, with all 7 directors present, and the meeting complied with legal and regulatory requirements [1] - The financial report for the first half of 2025 was approved by the board's audit committee with a voting result of 6 in favor and 1 against [2] - The company appointed Mr. Wang Xiangting as the deputy general manager and board secretary, with the term lasting until the end of the current board's term [2][3] Group 2 - Independent director Mr. Jing Naiquan abstained from voting on the appointment of Mr. Wang, citing the need for more attention to detail and professionalism [3][4] - Director Ms. Bao Jia voted against the half-year report, raising concerns about a significant related party transaction that exceeded regulatory thresholds [5][10] - The company clarified that the related party transactions had been previously approved by the board and reported to regulatory authorities [13][18] Group 3 - The company emphasized that the appointment of Mr. Wang met all legal qualifications and was supported by a thorough background check [4][12] - Ms. Bao expressed concerns about Mr. Wang's lack of recent experience in securities affairs and questioned his professional capabilities [11][19] - The company defended its governance practices, stating that all high-level changes followed proper procedures and aimed to enhance operational efficiency [17][19]
可靠股份: 监事会决议公告
Zheng Quan Zhi Xing· 2025-08-24 16:16
Meeting Details - The fifth meeting of the supervisory board of Hangzhou Reliable Nursing Products Co., Ltd. was held on August 21, 2025, in Hangzhou, with all three supervisors present [1] - The meeting was chaired by Mr. Ren Shaonan and complied with relevant laws, regulations, and the company's articles of association [1] Supervisory Board Resolutions - The supervisory board approved the company's 2025 semi-annual report and its summary, confirming that the preparation and review processes met legal and regulatory requirements, and accurately reflected the company's operational status for the first half of 2025 [1][2] - The board voted unanimously in favor of the report, with 3 votes for, 0 against, and 0 abstentions [2] Fund Management - The supervisory board confirmed that the company adhered to relevant laws and regulations regarding the management and use of raised funds, with no instances of misappropriation or harm to shareholder interests [2] - The report on the storage and use of raised funds for the first half of 2025 was also deemed to be true, accurate, and complete, with no misleading statements or omissions [2]